Skip to main content
OpenTrials

Clinical trial condition

Resectable Esophagogastric Adenocarcinoma

Explore clinical trials studying Resectable Esophagogastric Adenocarcinoma. Study availability and eligibility vary by location and protocol.

1 public trial 1 recruiting study
Refine in advanced search Browse all conditions

Resectable Esophagogastric Adenocarcinoma trial results

Recruiting

A Phase Ib Trial Evaluating the Safety and Activity of Neoadjuvant Combination of Tislelizumab Plus FLOT for Resectable Esophagogastric Adenocarcinoma

NCT07059299

Conditions
Adenocarcinoma Of Esophagus, Digestive System Diseases, Digestive System Neoplasms, +11 more
Locations
  • Krankenhaus Nordwest GmbH Institut für Klinisch-Onkologische Forschung (IKF) Frankfurt, Germany
  • Hämatologisch-Onkologische Praxis Eppendorf (hope) Hamburg, Germany
  • Universitätsklinikum Leipzig Leipzig, Germany
  • Klinikum rechts der Isar München der TU München München, Germany
View Trial Details

Related conditions